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Shiga toxin B-subunit (STxB), a protein involved in the cell-binding and intracellular trafficking of Shiga holotoxin, binds to a specific
glycolipid, the globotriaosyl ceramide (Gb3). Tryptophan residues of STxB, located at the protein–membrane interface, allow one to study its
interaction with model membranes by means of spectroscopic methods with no need for chemical derivatisation with a fluorophore. The protein
emits maximally around 346 nm and a blue shift of about 8 nm, as well as the occurrence of changes in the emission fluorescence intensity spectra,
is indicative of insertion and partition into the membrane. However, the interaction seems to take place without pentamer dissociation. Acrylamide
quenching experiments confirm tryptophan residues become less exposed to solvent when in the presence of vesicles, and the use of lipophilic
probes suggests that they are located in a shallow position near the water/membrane interface. Fluorescence intensity and lifetime measurements
upon STxB titration with Gb3-containing vesicles suggest a complex STxB/Gb3 docking mechanism involving static quenching in the later stages.
Based on our observations, a model of the protein–membrane interaction is proposed and the STxB membrane partition and binding constants
were calculated.
© 2007 Elsevier B.V. All rights reserved.Keywords: Shiga toxin B-subunit; Globotriaosyl ceramide; Fluorescence; Lipid vesicles1. Introduction
Shiga toxin is a bacterial protein produced by Shigella
dysenteriae and is structurally related to verotoxins and cholera
toxin, all of which belong to the AB5 toxins family [1]. It is
composed of two subunits with distinct functions. Infections
with bacteria producing Shiga and Shiga-like toxins are
responsible for widespread disease and for the death of a large
number of humans [2], and increasing knowledge about theAbbreviations: STxB, Shiga toxin B-subunit; CD, circular dichroism; LUV,
large unilamellar vesicles; Trp, tryptophan; Gal, galactose; Glc, glucose; Suc,
sucrose; POPC, 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine; DPPC, 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleyl-sn-gly-
cero-3-[phospho-rac-(1-glycerol)]; 5NS, 5-doxyl-stearic acid; 16NS, 16-doxyl-
stearic acid
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doi:10.1016/j.bbamem.2006.12.011toxin–cell interaction is a fundamental requisite for the
efficient production and application of molecules that might
help to treat those types of infections. The monomeric A-
subunit has a N-glycosidase enzymatic activity leading to the
inhibition of protein synthesis and cell death, whereas the B-
subunit (STxB) is a homopentamer responsible for the
receptor binding, internalisation and intracellular transport of
the holotoxin [3–6]. STxB has been extensively used in cell
biology research as a tool for the characterisation of the so-
called retrograde transport, a pathway going directly from
early endosomes to Golgi apparatus and ER in some cell types
[7–11].
The Shiga toxin receptor is a glycosphingolipid termed
globotriaosyl ceramide (Gb3 or CD77), being STxB among the
smallest known lectins [12]. It is strongly expressed on human
tumors [13,14] and the use of STxB in cancer therapy has been
suggested [15–18]. STxB is also developed as a vector to bring
epitopes into the cytosol [19], as it has been shown that B-
subunit alone is fully functional in terms of membrane binding
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Shiga toxin apparently uses the retrotranslocation machinery to
have access to the cytosol [22], as do other protein toxins [23], it
is not clear by what mechanism STxB crosses membranes in
antigen presenting cells even though such translocation has
clearly been shown [24]. Neither is it known if the interaction of
STxB with the membranes induces conformational changes on
the protein. The aim of this study is to understand the interaction
of STxB with model membranes.
STxB is composed of five identical monomers of 69 residues
(7.7 kDa). The three-dimensional structure of STxB and
holotoxin has been solved both by NMR and X-ray crystal-
lography, showing for the B-subunit a pentameric ring-like
conformation with a central pore delimited by α-helices from
each monomer and surrounded by antiparallel β-sheets [25–
27]. Each monomer is thought to have up to three binding sites
for Gb3 molecules (reported as site 1, 2, and 3) [28], although
NMR studies suggest only one molecule is bound per monomer
[29]. This could be the situation existing in physiological
conditions, as it seems not all three binding sites are relevant for
binding. The first binding site is located at the cleft of adjacent
monomers and involves hydrophobic stacking interaction of
Phe30 residue with the terminal Gal of receptor and hydrogen
bonds with proximal polar residues. Site 2, believed to be theFig. 1. Localisation of tryptophan residues in the STxB three-dimensional
structure. Trp residues are solvent exposed in aqueous buffer and located at the
protein–membrane interface when in presence of vesicles. Figure was produced
with the PyMol software program using X-ray crystallographic coordinates from
Brookhaven PDB ID 1BOS.higher affinity binding site, is located in the opposite side of
Phe30 phenyl ring and involves mainly hydrogen bonds with
the trisaccharide. Finally, it is believed Trp34, just at the
beginning of each one of the α-helix motifs, interacts with Gb3
by hydrophobic stacking in the third binding site. However,
receptor binding can still occur after deleting the Trp residue
[30]. Trp residues are located in the protein membrane interface
and are solvent exposed in the native 3D-crystal conformation
(Fig. 1).
The position of Trp within STxB structure enables the
application of fluorescence spectroscopy techniques for the
study of its interaction with lipid vesicles with no need of
derivatisation with a fluorescent probe. A previous paper reports
fluorescence spectroscopy studies on the STxB interaction with
Gb3-containing vesicles before the protein's three-dimensional
structure was determined [31]. The main observations were the
existence of a solvent-exposed Trp in solution (later confirmed
by the 3D-structure determination) and the occurrence of a blue
shift and increase in fluorescence emission intensity upon
addition of Gb3-containing membranes. However, these studies
were performed in small unillamelar vesicles (SUV), which
have an artefact-generating high curvature radius. Moreover, no
physical explanation of the process observed was stated. In this
paper we have characterised the photophysics of STxB in
aqueous buffer and in presence of large unillamelar vesicles
(LUV) of different lipid composition and Gb3, mainly by means
of steady-state and time-resolved fluorescence spectroscopy, to
obtain insights about the mode of interaction of the protein with
lipid membranes and propose a physical model.
2. Materials and methods
2.1. Materials
POPC (1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine), POPG (1-palmi-
toyl-2-oleyl-sn-glycero-3-[phosphor-rac-(1-glycerol)]) and DPPC (1,2-dipalmi-
toyl-sn-glycero-3-phophocholine) were purchased from Avanti Polar-Lipids
(Alabaster, AL), and globotriaosylceramide (Gb3) from Matreya LLC (Pleasant
Gap, PA). Cholesterol was from Sigma (St. Louis, MO) and 5NS (5-doxyl-
stearic acid) and 16NS (16-doxyl-stearic acid) were from Aldrich Chem. Co.
(Milwaukee, WT). HEPES, NaCl, L-tryptophan, acrylamide, ethanol, chloro-
form, D-Galactose, D-Glucose, D-Sucrose and urea were purchased from Merck
(Darmstadt, Germany).
2.2. Protein preparation
Recombinant B-subunit was expressed in E. coli by heat induction at 42 °C
of a pSU108 plasmid containing the STxB gene sequence, and was purified by
an osmotic shock procedure followed by two consecutive chromatography steps,
first an anion exchange column followed by an affinity column, as described
elsewhere [32]. Purity of the samples were checked by Tris/Tricine SDS-PAGE,
and protein concentration was determined spectroscopically using the extinction
coefficient value of 9500 M−1 cm−1 at 278 nm for the monomer [33]. 10 mM
HEPES, pH 7.4, 150 mM NaCl buffer was used throughout all studies (aqueous
buffer) and experiments were carried out at 20 °C.
2.3. Vesicles preparation
Large unilamellar vesicles (LUV), with typical 100 nm diameter were
prepared by the extrusion method described elsewhere [34]. All glycolipid-
containing LUV were prepared with 5 mol% Gb3. Lower contents of Gb3 was
Fig. 2. Photophysical characterization. (A) Normalised emission spectra
(λexc=280 nm) for STxB in aqueous buffer (solid line) and in the presence of
1.5 mM POPC/Gb3 (dotted line) LUV. Inset shows changes of molar ellipticity
in the far-UV CD region for STxB in aqueous buffer (solid line), 1.5 mM POPC/
Gb3 vesicles (○), and 8 M urea (▵). (B) Changes in maximum intensity
emission wavelength as a function of POPC/Gb3 (●) and pure POPC (○)
concentration.
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experimental limitations.
2.4. CD spectroscopy
CD spectra in the far-UV (200–250 nm) were recorded in a Jasco J720
spectropolarimeter, using a 1 mm path length circular cuvette. The protein
concentration was ca. 0.02 mM. Spectra are averages of five scans and were all
background-corrected, smoothed using J720 noise reduction software and
converted to molar ellipticity ([Θ]=Mres Θobs l
−1 p−1), where Mres=111.5 is
the mean residue molar mass (in daltons), Θobs is the ellipticity measured
(degrees) at wavelength λ, l is the optical path length of the cell (mm) and p is
the protein concentration (mg/ml).
2.5. Steady-state fluorescence studies
STxB has a tryptophan residue per monomer, which make fluorescence
techniques suitable tools. All fluorescence measurements were performed with a
Fluorolog-3 spectrofluorimeter from Jobin-Yvon/Horiba, and acquired with
DataMax v2.20 software programme. Samples were excited at 280 nm (for
REES experiments excitation wavelength varied from 280 to 300 nm) and
emission spectra were collected from 300 to 450 nm and were blank corrected.
All spectra were also corrected with the instrumental correction function.
Excitation and emission slits with a 4 nm bandpass were used for all
measurements.
Membrane partition studies were performed by successive additions of small
volumes of LUV (stock concentration of 15 mM) to a 0.4 ml sample with ca.
0.01 mM protein, with a 10 min incubation in between. Fluorescence intensity
data were corrected for dilution and inner filter effects.
Fluorescence anisotropy was calculated from:
r ¼ Ivv  GIvh
Ivv þ 2GIvh ð1Þ
The two subscripts in I are used to indicate the orientation of the excitation and
emission Glan–Thompson polarizers, respectively (v—vertical, h—horizontal).
G= Ihv/Ihh is an instrumental correction factor.
2.6. Time-resolved fluorescence studies
Fluorescence lifetimes acquisitions were monitored using the TCSPC
accessory, with a 280 nm LED laser source (IBH, UK). Lifetimes were
calculated from time-resolved fluorescence intensity decays using 10 Kcounts in
the peak channel. Fluorescence intensity decay curves were deconvoluted with
the instrument software DAS6 (IBH, UK) and analysed as a sum of exponential
terms. The mean average lifetime, hτi is:
hsi ¼
P
ais2iP
aisi
ð2Þ
ai is the pre-exponential factor and τi is the fluorescence lifetime of each i
component [35]. The goodness of the fit was judged from the global chi-square
value and weighted residuals.
2.7. Quenching experiments
Quenching studies were carried out by successive additions of small
amounts of acrylamide, galactose, glucose and sucrose stocks. Excitation
wavelength was 280 nm, except for acrylamide titration where it was set at
290 nm to minimise the relative quencher/fluorophore light absorption ratio, and
inner filter effect was negligible under these experimental conditions.
Data were fitted by the Stern–Volmer equation [35]:
I0
I
¼ 1þ KSV Q½  ð3Þ
where I0 and I are the fluorescence intensities in the absence and presence of the
quencher (acrylamide or carbohydrates), respectively, [Q] is the molar quencher
concentration, and KSV is the Stern–Volmer constant.Membrane in-depth location of STxB Trp residues was studied using 5NS or
16NS as quenchers [36]. Titration of ca. 0.01 mM STxB in presence of 1.5 mM
POPC/Gb3 LUV was carried out by addition of aliquots of 5NS and 16NS stock
solutions (70 mM in ethanol). Final ethanol concentration was kept below 2%
(v/v). Assays were followed at λex=290 nm and λem=340 nm.3. Results and discussion
3.1. Photophysical characterisation of STxB
The spectral characteristics of STxB are dominated by the 5
Trp residues (one in each monomer). Interaction of the protein
with LUV can be followed by the changes in several
spectroscopic parameters, namely, fluorescence intensity, spec-
tral shifts, and fluorescence lifetimes. Normalised emission
fluorescence spectra of STxB in aqueous buffer and in the
presence of 1.5 mM of POPC/Gb3 vesicles are represented in
Fig. 2A. In aqueous buffer, the emission intensity maximum
wavelength (λmax) occurs at ∼346 nm (after blank and
instrumental correction), indicating solvent exposure of Trp
residues (free Trp emits maximally at ∼350 nm under the same
experimental conditions). Upon addition of LUV, λmax is blue
shifted to a maximum of ∼338 nm. This is an evidence of the
interaction of the protein with the model membranes. However,
the far-UV CD spectrum of STxB in the presence of vesicles is
Fig. 3. Red-edge excitation shift. Variation of maximum intensity wavelength of
the emission spectra at different excitation wavelengths for STxB in aqueous
buffer (■), in presence of 1.5 mM POPC/Gb3 vesicles (●), and denatured by
8 M urea (○). Each point is the average of two determinations and lines are
merely guides to the eye.
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solution (inset in Fig. 2A). Thus, it seems that addition of LUV
do not induce major conformational changes in the protein
secondary structure, and STxB retains its pentameric con-
formation when interacting with membranes (the spectrum of
STxB dissociation in the presence of 8 M urea is shown).
Although separation of the pentamer into five monomers
retaining their secondary-level structure upon interaction with
lipids could, in principle, be speculated, steady-state anisotropy
data do not support this hypothesis. Immobilisation of
monomers in the membrane matrix would lead to an increased
value of fluorescence anisotropy. At variance, the measured
fluorescence anisotropy remains constant (r∼0.03–0.06). Such
a low value in a viscous medium and moderate excited-state
lifetime species like Trp residues in lipid bilayers can only be
due to energy migration depolarisation [37]. Significant energy
migration occurs when fluorophores are in close vicinity of
each other, which is the case for tryptophan residues in the
STxB pentamer, as the distance between each indole group is
4–6 Ånsgtrom (see Fig. 1), according to the available crystal-
lographic data [25,26].
The same qualitative blue shift and vibrational progression
(i.e. the “shape” of the spectra) described before were obtained
when incubating STxB with vesicles composed of other lipids.
STxB is slightly acidic (pI=5.7) and has a negative charge at
neutral pH. However, the pH at the proximity of the membrane
surface is believed to be lower, and STxB probably has a
negligible charge in this microenvironment. Thus, no sig-
nificant effect on the STxB interaction with membranes was
observed when negatively charged POPC:POPG (80:20), gel
phase forming lipid, DPPC, and cholesterol-containing, i.e.
POPC:Cholesterol (82:18 and 67:33) vesicles were tested
(cholesterol decreases membrane fluidity at room temperature).
Nevertheless, the blue shift observed in the presence of Gb3-
free vesicles is linearly LUV concentration-dependent, whereas
it is exponentially dependent for Gb3-containing vesicles (Fig.
2B). This is probably due to the more efficient incorporation of
protein in the presence of its natural receptor, reaching
saturation at ∼1.5 mM lipid concentration, whereas the
spectral changes observed with Gb3-free vesicles are non-
specific. These results do not agree with a previous report
stating that no interaction occurs between STxB and Gb3-free
vesicles [31].
3.2. Red edge excitation shift
The red edge excitation shift (REES), usually observed for
mobility restricted polar fluorophores, can be described as the
increase in the wavelength of maximum emission observed
when the excitation wavelength is gradually shifted towards the
red edge of the absorption band. Thus, REES is appropriate to
obtain information on the organisation and dynamics of the
fluorophore environment, including Trp residues in proteins
[38,39]. The variation of the wavelength of maximum emission
with the increase of the excitation wavelength for STxB in
aqueous buffer, and in the presence of vesicles is presented in
Fig. 3. A large REES (∼17 nm when excitation wavelengthvaries from 280 to 300 nm) is observed for native STxB in
aqueous buffer. This observation is very uncommon, as REES is
usually observed only in viscous or in mobility restricted
conditions and in proteins with maximum emission wave-
lengths between 325 and 340 nm (when λex=280 nm) [38]. In
our case, although STxB pentamers do not aggregate in solution
(as confirmed by analytical ultracentrifugation experiments
[40]), the particular organisation of Trp residues in the pentamer
conformation (see Fig. 1) can imply a restriction in mobility and
affect their photophysical properties. Supporting this hypothesis
is the observation that when STxB is chemically unfolded and
dissociated by incubation with 8 M urea, although being a more
viscous solution, a REES of only 4 nm is observed when the
excitation wavelength is changed from 280 to 300 nm (open
circles in Fig. 3) confirming the increase of Trp mobility
compared with the native conformation. Denatured proteins
exhibiting REES are scarce because this observation means that
Trp residues are partially shielded from the bulk solvent [41].
The presence of lipid does not significantly change REES in
comparison to the aqueous buffer conditions as STxB maintains
its pentameric structure when in contact with membranes (see
above).
3.3. Fluorescence quenching
In order to evaluate the localisation of Trp residues of STxB
when interacting with the model membranes, fluorescence
quenching by the lipophilic probes 5NS and 16NS was used.
These two derivatised fatty acids differ in the position of the
quencher moiety (doxyl) along the hydrocarbon chain. Thus,
they are used to determine the depth of the fluorophore in the
membrane, by comparing the quenching results obtained with
each of them. Steady-state fluorescence quenching measure-
ments were performed with fixed concentrations of STxB and
lipid, and increasing concentration of quenchers. Fig. 4A shows
the variation of I0/I as a function of local lipophilic probe
concentration in membranes for STxB in the presence of
1.5 mM POPC/Gb3 vesicles. It is clear that STxB Trp
fluorescence is more extensively quenched by the 5NS probe
Fig. 5. Membrane partition curves. Titration curves of STxB as a function of
POPC/Gb3 (●, ■) and pure POPC (○, □) concentration obtained from
fluorescence intensity (●,○) and lifetimes (■,□) experiments. Lines represent
non-linear regression fits (see text for details).
Fig. 4. Stern–Volmer plots. (A) Quenching by the derivatised lipophilic
molecules 5NS (●) and 16NS (○) in the presence of 1.5 mM POPC/Gb3
vesicles. (B) Quenching by acrylamide of STxB in buffer (●), and in presence of
1.5 mM POPC/Gb3 vesicles (○). (C) Quenching by different carbohydrates:
galactose (●), glucose (○), and sucrose (■).
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− 1) as compared to 16NS (KSV=3.88±
0.15 M− 1), suggesting that the fluorophore is located in a
shallow position at the water/membrane interface. This
confirms that the protein's structural motifs are not being
significantly perturbed by the presence of membranes.
The effect of acrylamide on the STxB Trp fluorescence is
represented in Fig. 4B. Linear Stern–Volmer plots are indicative
of all Trp residues being fairly accessible to acrylamide. STxB
in aqueous buffer has a KSV=20.8±0.9 M
− 1, similar to that
reported for the model compound N-acetyltryptophanamide,
NATA [42], and upon addition of LUV KSV decreases twofold
(KSV=11.5±0.5 M
− 1), due to the involvement of Trp residues
in the protein–membrane interaction. Previous work stated a
non-linear Stern–Volmer plot for the protein in the absence of
lipid that we were not able to detect [31,43]. According to our
data static and dynamic quenching do not co-exist.Titration of STxB with different carbohydrates shows a
quenching of STxB Trp in the presence of galactose, glucose
and sucrose saccharides up to 40–50 mM concentration (Fig.
4C), with no alteration of lifetimes values (data not shown).
Taking into account the local glycolipid concentration in the
membrane volume itself (ca. 65 mM when considering the lipid
molar volume to be 0.763 dm3 mol− 1 [44]), the Gb3
carbohydrate moiety can have a noticeable quenching effect
on the STxB fluorescence.
3.4. Determination of partition and binding constants
Fluorescence intensity of STxB titrated with 5 mol% Gb3-
containing POPC vesicles increases until reaching a maximum
at 1.5 mM lipid concentration, followed by a decrease (solid
circles in Fig. 5). This is a unique characteristic of Gb3-
containing vesicles, since the absence of it induces a slight
decrease of fluorescence intensity for all lipid composition
vesicles tested (open circles in Fig. 5). This observation is in
contrast with a regular increase of average fluorescence lifetime,
hτi, for POPC/Gb3 LUV titration (solid squares in Fig. 5). hτi
for STxB is described by a sum of not less than three
exponentials, with a mean lifetime of 4.3 ns in aqueous
solution. In the presence of POPC/Gb3 vesicles, this value is
increased (up to 7.3 ns for [L]= 3.0 mM). Lifetimes constantly
increase upon Gb3-containing vesicles addition, even after
reaching the maximum fluorescence intensity at ∼1.5 mM
lipid concentration. hτi for other LUV compositions were
determined (DPPC, POPC:POPG), with no significant changes
compared to STxB in aqueous buffer. Even the insertion of
10 mol% of a monossacharide-acyl in liposomes had the same
effect as pure vesicles, confirming the specificity of spectral
changes observed only for the interaction between the Gb3
trisaccharide moiety and STxB. Therefore, partition into Gb3-
free vesicles causes quenching of STxB fluorescence, which is
mainly static, while Gb3-containing vesicles cause an increase
on fluorescence intensity first (up to 1.5 mM lipid concentra-
tion) and a pronounced static quenching afterwards.
In a first attempt to quantify the extent of interaction of STxB
with the membrane, the apparent partition coefficient between
Fig. 6. Schematic representation of the proposed interaction between STxB and
Gb3-containing lipid vesicles. STxB is a soluble globular pentamer in solution
and binds to its natural receptor, the glycolipid Gb3 (solid diamonds-glycidic
moieties) in membranes after an intermediate step of direct interaction with lipids
(A). Once at the membrane surface with empty binding sites, STxB remains
pentameric in a shallow position and suffers small structural changes leading to a
slight static quenching of Trp fluorescence. It probably has the ability to cluster
Gb3molecules in its vicinity, as 5 to 15 binding sites (empty diamonds) have been
reported per pentamer.When fewGb3 molecules are available for binding, nearly
all dock in high affinity binding sites (B), which do not directly involve Trp
residues. However, docking to these sites induce changes in their Trp excited-
state lifetimes and fluorescence quantum yields probably via local conforma-
tional changes. Once high-affinity binding sites are saturated, all binding sites are
occupied by Gb3 molecules, including the ones in direct contact with Trp, which
lead to a static quenching of fluorescence intensity (C).
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derived formalism based on the fluorescence lifetime averaged
by the pre-exponentials, τ¯ :
s¯ ¼
P
aisiP
ai
ð4Þ
The use of τ¯ instead of hτi for the Kp,App calculation is
advantageous because it does not require the knowledge of the
molar absorptivity, and consequent errors related to its
determination are avoided. Kp,App can be obtained from the
following relationship (see appendix of [45] for details):
s¯
s¯W
¼ 1þ
s¯
L
s¯W
KpgL L½ 
1þ KpgL½L
ð5Þ
where τ¯W and τ¯L are the fluorescence lifetimes averaged by the
pre-exponentials for STxB in the aqueous and membrane
phase, respectively, γL is the molar volume of the phospho-
lipids, which for POPC corresponds to 0.763 M− 1 [42], and
[L] is the molar lipid concentration accessible to the protein
(the outer leaflet of the bilayer, i.e. half of the total lipid
concentration). By the non-linear regression fit of τ¯/ τ¯W versus
[L] data (line through solid squares in Fig. 5), one obtains an
apparent Kp,App of (6.2±0.5)×10
3, which corresponds to a
ΔG of −7.4 kcal mol− 1. A more detailed and realistic
description of the STxB/Gb3 interaction is to consider the
combined effect of STxB partition to membranes, subsequent
Gb3 docking to a specific binding site (an increase in quantum
yield resulting there from) and, finally, docking to the
remaining binding sites, leading to the static quenching
observed at higher lipid concentrations. Fig. 6 illustrates this
model. However, while this model appears the most plausible
to us, other interpretations cannot be excluded. If one considers
the interaction between STxB and non-Gb3 containing vesicles
only, i.e. the interaction between the protein and the membrane
surface before Gb3 contacts with the binding sites, Kp can be
calculated from changes in intensity upon lipid addition (open
circles in Fig. 5) using the analogue formalism I/Iw (see
equation in [46]). Kp for pure POPC vesicles is (1.4±
0.2)×103.
The binding constant (KB in Fig. 6) can be calculated using a
more complex formalism (derived in Appendix), which
accounts for simultaneous partition and binding. For the sake
of simplicity it was assumed that docking to the last binding
sites only occurs when the first binding site is completely
saturated. The biphasic dependence observed in Fig. 5 (solid
circles) supports this to a reasonable approximation. Non-linear
regression analysis on the data up to 1.2 mM lipid concentration
leads to a KB of 0.0123±0.0051 mM
− 1. Whilst at a first glance
this value may seem well below others that have been reported
in the literature [47], it should be stressed that this KB refers to
the local concentration in the membrane, whereas an apparent
constant referring to bulk analytical concentrations would be
much higher (by three orders of magnitude, depending on [L])
but a poorer description of the process at the molecular level
(see Appendix for further details). It is the combined effect ofmembrane partition and binding in the confined space of the
membrane that favors STxB/Gb3 association.
4. Conclusion
STxB interacts with model membranes, independent of its
lipid composition, as supported by changes in fluorescence
intensity and blue shifts occurring upon addition of LUV, without
significant secondary structure conformational changes (as
indicated by CD experiments). However, in pure POPC vesicles,
the protein seems to interact non-specifically with the membrane
surface leading to a slight decrease in fluorescence intensity and
excited-state lifetimes. The presence of 5 mol% of Gb3 glycolipid
receptor induces an increase in fluorescence intensity as well as
lifetimes. Several studies have shown that Shiga toxin is
associated with detergent resistant membranes [9,48,49] suggest-
ingmicrodomains clustering in biological membranes. If Gb3 was
associated with nanoclusters, as recently suggested for GPI-
anchored proteins [50], this could favor the initial binding to
membranes. As a consequence, the relatively high glycolipid
concentration in vitro can be interpreted as the accumulation of
Gb3 in lipid rafts in vivo. Fluorescence intensity reaches a
maximum at 1.5 mM of POPC/Gb3 vesicles, followed by a
progressive decrease, which is not accompanied by lifetimes.
Lifetimes reach a plateau. A REES value of∼17 nm for STxB in
aqueous buffer is a quite surprising observation. It suggests Trp
residues are already mobility-restricted under these conditions.
The pentamer is highly soluble and aggregation does not occur.
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REES results. Quenching studies indicate that the STxB Trp
residues remain at the membrane interface (5NS has a greater
apparent quenching efficiency than 16NS and acrylamide is
partially accessible to indoles). Carbohydrates are also able to
quench Trp, at least to a physiologically relevant concentration
(40–50 mM).
As a soluble globular protein, STxB runs at the membrane
surface until it binds to its specific receptor Gb3 [51]. STxB
remains in a shallow position and pentameric even when
interacting with the glycolipid. The overall results obtained in
this study can be rationalised considering the model in Fig. 6. In
the first stage, STxB binds five Gb3 molecules in high affinity
binding sites (site 2 in [28]), which are not in direct contact with
Trp residues. Nevertheless, it induces micro-environment
changes responsible for the increase in fluorescence intensity
and lifetimes observed (up to 1.5 mM of vesicles). The protein
might have the ability to cluster Gb3 molecules in its vicinity,
and site 1 and site 3 can bind the glycolipid upon saturation, as
up to 15 Gb3 analogues have been reported to attach to STxB.
The third and less efficient binding site, which involves direct
contact of the glycolipid with Trp residues, leads to the static
quenching of fluorescence intensity observed at higher (above
1.5 mM) lipid concentration.
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Appendix
Consider the partition/binding multi-equilibria depicted in:
where S and G stand for the STxB monomer and Gb3
respectively, and Kp and KB are the equilibrium constants
referring to membrane partition from buffer (W) to lipid (L) and
binding in the lipid environment:
Kp ¼ ½SL½SW
ðA:1Þ
KB ¼ ½SGL½SL½GL
ðA:2Þ
S is fluorescent due to the presence of a Trp residue. The
fluorescence intensity, I, measured at given S, L, and G con-
centrations is:
I ¼ IFWXFW þ IFLXFL þ IBLXBL ðA:3Þwhere Iij refers to the limit fluorescence intensity that would be
attained if all S molecules would be located in environment j
(j=L, lipid; j=W, buffer) in conditions i (i=F, free, unbound;
i=B, bound) and Xij refers to the molar fraction of S meeting
condition i and location j.
Assuming that the lipid concentration, [L], is such that the
total lipid phase volume is much less than the aqueous phase
volume and combining Eqs. (A.2) and (A.3):
I
ISW
¼ ½SW þ b:gL L½ :
½GT;L  ½GL
KB½GL

þc:gL L½  ½GT;L  ½GL
 ½S1T ðA:4Þb ¼ IS;L
IS;W
ðA:5Þc ¼ ISG;L
IS;W
ðA:6Þ
where γL is the molar volume of the lipid (γL[L] is the volume
fraction of the lipid) and [G]T,L is the total concentration of G in
the lipid environment. [S]T is the total S concentration referring
to the whole sample volume.
Combining Eqs. (A.1) and (A.2):
½GL ¼
½GT;L
KpKB½SW þ 1
ðA:7Þ
[S]W is related to [S]T by:
½S2WKpKBð1þ gL½LKpÞ þ ½SW½ð1þ gL½LKpÞ
þ KpKBðgL½L½GT;L  ½STÞ  ½ST ¼ 0 ðA:8Þ
that can be simplified to:
½S2W:Aþ ½SW:Bþ C ¼ 0 ðA:9Þ
A ¼ KpKBð1þ gL½LKpÞ;
B ¼ ½ð1þ gL½LKpÞ þ KpKBðgL½L½GT;L  ½STÞ; C ¼ ½ST
ðA:10Þ
and rearranged:
½SW ¼
Bþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
B2  4AC
p
2A
ðA:11Þ
Combining Eqs. (A.7) and (A..4):
I
ISW
¼ 1þ b:gL L½ Kp
 þ c:gL L½ ½GT;L KpKBKpKB½SW þ 1
  ½SW
½ST
ðA:12Þ
Eqs. (A.11) and (A.12) were used to fit the I/ISW vs. [L]
experimental data (keeping [G]T,L constant; Gb3 5 mol%) and
thus obtain c and KB from non-linear regression (c=8.297±
635D.G. Pina et al. / Biochimica et Biophysica Acta 1768 (2007) 628–6362.404, KB=0.0123±0.0051 mM
− 1). Kp and b were previously
obtained in a different experiment where pure lipid was used
([G]T,L=0). Kp=1400 and b=0.113 (see Fig. 5). It should be
stressed that KB=0.0123±0.0051 mM
− 1 refers to the lipid
phase volume, where the concentration of S and G are increased
relative to the bulk analytical concentrations. This value can be
converted to an apparent constant referring to bulk volume. Such
apparent constant is much higher (by the order of the thousand,
depending on [L]), however it does not describe the system
adequately. It is the membrane partition and the binding effects
combined that favor SG association, not only KB by itself.
c=8.297±2.404 reflects an apparently very high increase in
quantum yield of SG relative to S in aqueous phase. This
probably results from the extremely rigid lipid environment
imposed by the Gb3 ceramide tails to the indole residues of
Trp34. Fig. 1 in the text show that these fluorophores in the
pentamer structure may become caged in a ceramide ring.
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